Hologic panther reagents option period 2, delivery order: 10/1/2023 to 9/30/2024

Ended Awarded Last action

Contract number
W81K0223F0129
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
Contract value 0% obligated
$574,594.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
South Korea

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Hologic panther reagents for bdaach option period 2: 10/1/2023 to 9/30/2024 descope and FY24 funding $574,595
Original award $0

About this award

Hologic Sales and Service, LLC, a subsidiary of Hologic, Inc. based in Marlborough, Massachusetts, was awarded a delivery order valued at $574,594.80 by the Defense Health Agency for Hologic Panther reagents during the option period from October 1, 2023 through September 30, 2024. The award is structured as a firm fixed-price delivery order with no set-aside designation, reflecting full and open competition. Performance is to be conducted in South Korea. The Panther reagents supplied under this delivery order support molecular diagnostic testing capabilities across the Defense Health Agency's healthcare system, providing essential in-vitro diagnostic consumables for clinical laboratory operations.

This delivery order represents one component of Hologic's extensive federal contract portfolio serving the Department of Defense and Defense Health Agency. The company maintains significant market presence through multiple contract vehicles with the Defense Health Agency and other federal healthcare agencies, leveraging its established manufacturing capabilities and technical expertise in advanced diagnostic equipment and laboratory reagents. The firm fixed-price structure provides cost certainty for the government while enabling efficient procurement of critical diagnostic supplies essential to military healthcare operations.

Quick answers

Who was awarded contract W81K0223F0129?

W81K0223F0129 was awarded to Hologic Sales And Service, LLC by Medical Command (Department of the Army) on October 1, 2023.

How much is contract W81K0223F0129 worth?

The government has obligated $0 on W81K0223F0129. Its current value, with exercised options, is $574,595.

Which agency awarded contract W81K0223F0129?

Medical Command (Department of the Army) awarded W81K0223F0129, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0223F0129 an order under another contract?

Yes. W81K0223F0129 is a delivery order under W81K0222D0003, an indefinite delivery contract.

Was contract W81K0223F0129 competed?

The extent of competition for W81K0223F0129 was full and open competition after exclusion of sources.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award